Study Of Soy Labs’ Lunasin Demonstrates Its Cholesterol Lowering Properties
A new in vitro study of Lunasin has demonstrated its potential to reduce cholesterol levels by inhibiting the expression of a gene known to be responsible for internal cholesterol production and increasing expression of a gene which reduces plasma LDL cholesterol. A recently
Original post by Women’s Health / Gynecology News From Medical News Today
Related Articles
VAP analysis Helps Researchers Uncover Best Cholesterol Lowering Treatment For Type II Diabetes Study Of Cholesterol-Lowering Drugs And Healthy Eating Abbott’s Investigational SIMCOR® Offers Comparable LDL Lowering To Simvastatin And Significantly Raises HDL And Lowers Triglycerides In Phase III Cholesterol-Lowering ability Of Dietitian Visits We Are What We Eat: Lowering Cholesterol The Old-Fashioned Way
